MMTV-Espl1 transgenic mice develop aneuploid, estrogen receptor alpha (ERα)-positive mammary adenocarcinomas.
about
Genetically engineered ERα-positive breast cancer mouse models.E2F activators signal and maintain centrosome amplification in breast cancer cells.The CINSARC signature as a prognostic marker for clinical outcome in multiple neoplasmsOverexpression and constitutive nuclear localization of cohesin protease Separase protein correlates with high incidence of relapse and reduced overall survival in glioblastoma multiformeClonal Evolution and Blast Crisis Correlate with Enhanced Proteolytic Activity of Separase in BCR-ABL b3a2 Fusion Type CML under Imatinib TherapyMeasurement of separase proteolytic activity in single living cells by a fluorogenic flow cytometry assayc-MYB is a transcriptional regulator of ESPL1/Separase in BCR-ABL-positive chronic myeloid leukemiaSeparase is a marker for prognosis and mitotic activity in breast cancer.Separase: Function Beyond Cohesion Cleavage and an Emerging Oncogene.Living in CIN: Mitotic Infidelity and Its Consequences for Tumor Promotion and Suppression.Biology and insights into the role of cohesin protease separase in human malignancies.Combined analysis identifies six genes correlated with augmented malignancy from non-small cell to small cell lung cancer.Positive and negative regulation of vertebrate separase by Cdk1-cyclin B1 may explain why securin is dispensable.Increased separase activity and occurrence of centrosome aberrations concur with transformation of MDS.Aging Mouse Models Reveal Complex Tumor-Microenvironment Interactions in Cancer Progression.Separase Inhibitor Sepin-1 Inhibits Foxm1 Expression and Breast Cancer Cell Growth.The Metabolism of Separase Inhibitor Sepin-1 in Human, Mouse, and Rat Liver Microsomes.Expression and prognostic value of cell-cycle-associated genes in gastric adenocarcinoma.
P2860
Q33578641-D0D438A8-7C49-472F-BDF9-7CA050561542Q33899840-01E66FB2-DCA5-44AE-AD70-11CBB6DDEC9AQ33905783-8453B7C7-5843-4CD0-B878-A5F8A68486F5Q34159936-95F16633-24B7-4451-B6DE-2A396CA8FE1BQ35667438-072A7F26-0446-4B40-8303-441A4C7263EAQ35743803-5DB8B433-3A1B-4506-8377-D110C214D753Q36639038-0BBF8F9C-BFE9-48F2-93F1-EB86E4BFEACBQ38599786-A27923C2-B7B5-4AA5-B654-DC011EEF6CCFQ39038164-DAB4900A-4C27-4119-B685-448D9F79F248Q39044653-8A988C05-EC4C-476F-990E-6670CD0A6FE2Q39126022-6909F996-F234-4C2E-B390-3E9DC7754AABQ41389873-0AB10D24-B6F6-4B48-94D5-FD6D13A86C07Q43195442-DA3C9A8D-C7AB-474D-85E1-E3938F8B482DQ48165643-6698841F-692F-4A48-BBA8-EC4B32EE1187Q52322881-B1D51947-C5E1-40C0-9FF0-61DB84E7E35DQ54108531-5CD4C63D-5113-438D-B6EF-D7D25421AA4DQ55015741-A73CA034-4AB6-4836-A373-349064733252Q55416570-2FFEB99D-68A7-4FA9-97A8-313DF6D6AF29
P2860
MMTV-Espl1 transgenic mice develop aneuploid, estrogen receptor alpha (ERα)-positive mammary adenocarcinomas.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
MMTV-Espl1 transgenic mice dev ...... itive mammary adenocarcinomas.
@ast
MMTV-Espl1 transgenic mice dev ...... itive mammary adenocarcinomas.
@en
type
label
MMTV-Espl1 transgenic mice dev ...... itive mammary adenocarcinomas.
@ast
MMTV-Espl1 transgenic mice dev ...... itive mammary adenocarcinomas.
@en
prefLabel
MMTV-Espl1 transgenic mice dev ...... itive mammary adenocarcinomas.
@ast
MMTV-Espl1 transgenic mice dev ...... itive mammary adenocarcinomas.
@en
P2093
P2860
P356
P1433
P1476
MMTV-Espl1 transgenic mice dev ...... itive mammary adenocarcinomas.
@en
P2093
Daniel Medina
David G Edwards
Debananda Pati
Gouqing Ge
Malini Mukherjee
Nenggang Zhang
Pavel Sumazin
Pulivarthi H Rao
Shyam K Sharan
P2860
P2888
P304
P356
10.1038/ONC.2013.493
P407
P577
2013-11-25T00:00:00Z
P5875
P6179
1031064933